Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olive pollen allergens are a family of proteins present in the pollen of *Olea europaea* (olive tree), recognized as major causes of seasonal respiratory allergy, especially in Mediterranean regions where the olive tree is widely cultivated. The allergenic components are diverse, with at least 10 distinct molecules isolated and characterized, among which Ole e 1 is the most clinically relevant as it sensitizes over 70% of olive pollen-allergic patients. These allergens vary by protein family and structure: some are well-characterized enzymes or proteins, such as profilin (Ole e 2), calcium-binding proteins (Ole e 3, Ole e 8), superoxide dismutase (Ole e 5), lipid transfer protein (Ole e 7), and 1,3-beta-glucanase (Ole e 9); others, such as Ole e 1 and Ole e 6, lack clear homology to known proteins and have unknown biological functions in the plant. The proteins provoke IgE-mediated immune responses leading to symptoms of allergic rhinitis, conjunctivitis, and, in susceptible individuals, asthma. Diagnostic and therapeutic strategies target specific allergens, with component-resolved diagnostics identifying IgE reactivity to individual molecules, and allergen immunotherapy aiming to induce tolerance. Variation in allergen content exists between olive cultivars, which can affect diagnosis and treatment efficacy. Note: The query "Olive pollen allergens" is best treated as a class designation, not a single molecular target; for structured data, entries should be per individual allergen (e.g., "Ole e 1", "Ole e 2"), each with unique properties and clinical significance.
Immune modulation (allergen-specific immunotherapy modulates T-cell and B-cell responses to reduce allergic Th2 response and induce tolerance)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olive pollen allergen (Ole e 1).